Your browser doesn't support javascript.
loading
Lower probability and shorter duration of infections after COVID-19 vaccine correlate with anti-SARS-CoV-2 circulating IgGs.
Ronchini, Chiara; Gandini, Sara; Pasqualato, Sebastiano; Mazzarella, Luca; Facciotti, Federica; Mapelli, Marina; Frige', Gianmaria; Passerini, Rita; Pase, Luca; Capizzi, Silvio; Mastrilli, Fabrizio; Orecchia, Roberto; Natoli, Gioacchino; Pelicci, Pier Giuseppe.
Afiliación
  • Ronchini C; Clinical Genomics, European Institute of Oncology IRCCS, Milan, Italy.
  • Gandini S; Department of Experimental Oncology, European Institute of Oncology IRCCS, Milan, Italy.
  • Pasqualato S; Department of Experimental Oncology, European Institute of Oncology IRCCS, Milan, Italy.
  • Mazzarella L; Department of Experimental Oncology, European Institute of Oncology IRCCS, Milan, Italy.
  • Facciotti F; Department of Experimental Oncology, European Institute of Oncology IRCCS, Milan, Italy.
  • Mapelli M; Department of Experimental Oncology, European Institute of Oncology IRCCS, Milan, Italy.
  • Frige' G; Clinical Genomics, European Institute of Oncology IRCCS, Milan, Italy.
  • Passerini R; Division of Laboratory Medicine, European Institute of Oncology IRCCS, Milan, Italy.
  • Pase L; Occupational Medicine, European Institute of Oncology IRCCS, Milan, Italy.
  • Capizzi S; Medical Administration, CMO, IEO, European Institute of Oncology, IRCCS, Milan, Italy.
  • Mastrilli F; Medical Administration, CMO, IEO, European Institute of Oncology, IRCCS, Milan, Italy.
  • Orecchia R; Scientific Directorate, European Institute of Oncology IRCCS, Milan, Italy.
  • Natoli G; Department of Experimental Oncology, European Institute of Oncology IRCCS, Milan, Italy.
  • Pelicci PG; Department of Experimental Oncology, European Institute of Oncology IRCCS, Milan, Italy.
PLoS One ; 17(1): e0263014, 2022.
Article en En | MEDLINE | ID: mdl-35100309

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Inmunoglobulina G / Anticuerpos Antiidiotipos / Vacunas contra la COVID-19 / COVID-19 Tipo de estudio: Prognostic_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2022 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Inmunoglobulina G / Anticuerpos Antiidiotipos / Vacunas contra la COVID-19 / COVID-19 Tipo de estudio: Prognostic_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2022 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Estados Unidos